
Keywords: ایمپلنت شنوایی مغز; ABI; auditory brainstem implant; CAP; Categories of Auditory Performance; CDaCI; Childhood Development after Cochlear Implantation; CI; cochlear implant; FDA; Food and Drug Administration; Hz; hertz; kHz; kilohertz; NF2; Neurofibromatosis Type 2; NIDCD; N